{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:19:42Z","timestamp":1791991182855,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Scientific and Technological Project of Hunan Province","award":["2013FJ4079"],"award-info":[{"award-number":["2013FJ4079"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.neuroscience.2016.01.041","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T02:30:27Z","timestamp":1453689027000},"page":"28-38","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing A\u03b21\u201340 brain-to-blood efflux and peripheral uptake transport"],"prefix":"10.1016","volume":"322","author":[{"given":"Y.-X.","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-Y.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-X.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2016.01.041_b0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neurobiolaging.2013.07.029","article-title":"Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate","volume":"35","author":"Annweiler","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0010","article-title":"\u2019Vitamin D and cognition in older adults\u2019: updated international recommendations","author":"Annweiler","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/WNN.0b013e31826df647","article-title":"Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study","volume":"25","author":"Annweiler","year":"2012","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1742-2094-9-244","article-title":"Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden","volume":"9","author":"Briones","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2006.10.083","article-title":"Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells","volume":"1130","author":"Brown","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2012.09.014","article-title":"Amyloid-beta oligomer detection by ELISA in cerebrospinal fluid and brain tissue","volume":"433","author":"Bruggink","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0040","doi-asserted-by":"crossref","first-page":"32185","DOI":"10.1074\/jbc.271.50.32185","article-title":"The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1\u201342 in Alzheimer\u2019s disease","volume":"271","author":"Castano","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12640-013-9379-2","article-title":"Death by a thousand cuts in Alzheimer\u2019s disease: hypoxia\u2013the prodrome","volume":"24","author":"Daulatzai","year":"2013","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720507780362245","article-title":"Role of the blood\u2013brain barrier in the pathogenesis of Alzheimer\u2019s disease","volume":"4","author":"Deane","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0060","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4155\/fmc.12.51","article-title":"Is RAGE still a therapeutic target for Alzheimer\u2019s disease?","volume":"4","author":"Deane","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0070","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/jnc.12041","article-title":"1alpha,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells","volume":"123","author":"Durk","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0075","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1523\/JNEUROSCI.2711-13.2014","article-title":"1alpha,25-Dihydroxyvitamin D3 reduces cerebral amyloid-beta accumulation and improves cognition in mouse models of Alzheimer\u2019s disease","volume":"34","author":"Durk","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2010-101377","article-title":"A novel perspective for Alzheimer\u2019s disease: vitamin D receptor suppression by amyloid-beta and preventing the amyloid-beta induced alterations by vitamin D in cortical neurons","volume":"23","author":"Dursun","year":"2011","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-130416","article-title":"A new mechanism for amyloid-beta induction of iNOS: vitamin D-VDR pathway disruption","volume":"36","author":"Dursun","year":"2013","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0090","doi-asserted-by":"crossref","first-page":"e17553","DOI":"10.1371\/journal.pone.0017553","article-title":"The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons","volume":"6","author":"Gezen-Ak","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0095","doi-asserted-by":"crossref","first-page":"45897","DOI":"10.1074\/jbc.M407668200","article-title":"Systemic catabolism of Alzheimer\u2019s Abeta40 and Abeta42","volume":"279","author":"Ghiso","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-8118-8-20","article-title":"1Alpha,25-dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-beta peptide(1\u201340) from mouse brain across the blood-brain barrier","volume":"8","author":"Ito","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0110","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2174\/13816128113199990460","article-title":"Targeting CNS transporters for treatment of neurodegenerative diseases","volume":"20","author":"Jedlitschky","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.neurobiolaging.2007.07.001","article-title":"VDR gene variants associate with cognitive function and depressive symptoms in old age","volume":"30","author":"Kuningas","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0120","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijcard.2014.02.041","article-title":"Calcitriol modulates receptor for advanced glycation end products (RAGE) in diabetic hearts","volume":"173","author":"Lee","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0135","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.1882","article-title":"Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts","volume":"28","author":"Lisse","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0140","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0145","doi-asserted-by":"crossref","first-page":"H1485","DOI":"10.1152\/ajpheart.00645.2001","article-title":"Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation","volume":"282","author":"Mark","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0150","doi-asserted-by":"crossref","first-page":"12004","DOI":"10.1074\/jbc.M707607200","article-title":"The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors","volume":"283","author":"Martin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0155","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer\u2019s disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-121735","article-title":"1Alpha,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-beta phagocytosis and inflammation in Alzheimer\u2019s disease patients","volume":"34","author":"Mizwicki","year":"2013","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-2012-110560","article-title":"Genomic and nongenomic signaling induced by 1alpha,25(OH)2-vitamin D3 promotes the recovery of amyloid-beta phagocytosis by Alzheimer\u2019s disease macrophages","volume":"29","author":"Mizwicki","year":"2012","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0175","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1124\/dmd.113.052514","article-title":"In vitro investigation of amyloid-beta hepatobiliary disposition in sandwich-cultured primary rat hepatocytes","volume":"41","author":"Mohamed","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0180","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/461895a","article-title":"Neuroscience: Alzheimer\u2019s disease","volume":"461","author":"Mucke","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-2236(97)01168-5","article-title":"Alzheimer\u2019s disease: a re-examination of the amyloid hypothesis","volume":"21","author":"Neve","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0190","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2014.07.012","article-title":"Evidence for lymphatic Abeta clearance in Alzheimer\u2019s transgenic mice","volume":"71","author":"Pappolla","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0200","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/156720510793499066","article-title":"Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-beta clearance in Alzheimer\u2019s disease","volume":"7","author":"Pflanzner","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0205","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2014.01.023","article-title":"Differences in amyloid-beta clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling","volume":"79","author":"Qosa","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.07.008","article-title":"Low-density lipoprotein receptor-related protein 1: a physiological Abeta homeostatic mechanism with multiple therapeutic opportunities","volume":"136","author":"Sagare","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0215","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnagi.2014.00290","article-title":"New therapeutic approaches for Alzheimer\u2019s disease and cerebral amyloid angiopathy","volume":"6","author":"Saito","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1471-4159.2011.07213.x","article-title":"Targets for AD treatment: conflicting messages from \u03b3-secretase inhibitors","volume":"117","author":"Sambamurti","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0225","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0230","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Investig"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1326-7-55","article-title":"Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE) \u2013 and amyloid beta 1\u201342-induced signal transduction in glial cells","volume":"7","author":"Slowik","year":"2012","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2004.05.081","article-title":"Plasma beta-amyloid (A beta) 40 concentration, lipid status and age in humans","volume":"367","author":"Smith","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0245","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/jcbfm.2012.25","article-title":"Pathophysiology of the neurovascular unit: disease cause or consequence?","volume":"32","author":"Stanimirovic","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0250","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/jnr.22603","article-title":"Peripheral reduction of beta-amyloid is sufficient to reduce brain beta-amyloid: implications for Alzheimer\u2019s disease","volume":"89","author":"Sutcliffe","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsbmb.2011.01.001","article-title":"Calcitriol counteracts endothelial cell pro-inflammatory processes in a chronic kidney disease-like environment","volume":"124","author":"Talmor-Barkan","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0260","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","article-title":"Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver","volume":"23","author":"Tamaki","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0265","first-page":"937","article-title":"The role of amyloid in the pathogenesis of Alzheimer\u2019s disease","volume":"378","author":"Verbeek","year":"1997","journal-title":"Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0270","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nbd.2008.04.006","article-title":"LRP1 modulates APP trafficking along early compartments of the secretory pathway","volume":"31","author":"Waldron","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0275","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-008-0435-6","article-title":"Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia","volume":"116","author":"Yan","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0280","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/JAD-2011-101986","article-title":"Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AbetaPP transgenic mice","volume":"25","author":"Yu","year":"2011","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0285","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.expneurol.2009.07.033","article-title":"Pathological role of hypoxia in Alzheimer\u2019s disease","volume":"223","author":"Zhang","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0290","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.neurobiolaging.2012.06.012","article-title":"Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer\u2019s disease neuropathology in APPSwe\/PS1A246E transgenic mice","volume":"34","author":"Zhang","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2012.04.003","article-title":"Vitamin D receptor activation in a diabetic-like environment: potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways","volume":"132","author":"Zitman-Gal","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.neuroscience.2016.01.041_b0300","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/77397","article-title":"Clearance of amyloid beta-peptide from brain: transport or metabolism?","volume":"6","author":"Zlokovic","year":"2000","journal-title":"Nat Med"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:57:43Z","timestamp":1567540663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452216000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":60,"alternative-id":["S0306452216000695"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.041","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}